Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Moldiag Diseases Genes Support Contact

Lamin A/C

The LMNA gene encodes a nuclear matrix protein. Mutations in this gene lead to several diseases: autosomal recessive Emery-Dreifuss muscular dystrophy, autosomal dominant familial partial lipodystrophy type 2, autosomal dominant limb girdle muscular dystrophy type 1B, autosomal dominant dilated cardiomyopathy type 1A, autosomal recessive Charcot-Marie-Tooth disease type 2B1, autosomal dominant Hutchinson-Gilford progeria syndrome, and autosomal dominant Slovenian type heart-hand syndrome.

Genetests:

Clinic Method Carrier testing
Turnaround 5 days
Specimen type genomic DNA
Clinic Method Massive parallel sequencing
Turnaround 25 days
Specimen type genomic DNA
Clinic Method Genomic sequencing of the entire coding region
Turnaround 25 days
Specimen type genomic DNA
Clinic Method Multiplex Ligation-Dependent Probe Amplification
Turnaround 25 days
Specimen type genomic DNA

Related Diseases:

Familial partial lipodystrophy type 2
LMNA
Malouf syndrome
LMNA
Dilated cardiomyopathy 1A
LMNA

References:

1.

Fatkin D et al. (1999) Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.

external link
2.

Brodsky GL et al. (2000) Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement.

external link
3.

Taylor MR et al. (2003) Natural history of dilated cardiomyopathy due to lamin A/C gene mutations.

external link
4.

Charniot JC et al. (2003) Functional consequences of an LMNA mutation associated with a new cardiac and non-cardiac phenotype.

external link
5.

Sébillon P et al. (2003) Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations.

external link
6.

Mounkes LC et al. (2005) Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice.

external link
7.

Meune C et al. (2006) Primary prevention of sudden death in patients with lamin A/C gene mutations.

external link
8.

Lloyd DJ et al. (2002) A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies.

external link
9.

Cao H et al. (2000) Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy.

external link
10.

Shackleton S et al. (2000) LMNA, encoding lamin A/C, is mutated in partial lipodystrophy.

external link
11.

Speckman RA et al. (2000) Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C.

external link
12.

Garg A et al. (2001) Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a/c gene.

external link
13.

Schmidt HH et al. (2001) Dyslipemia in familial partial lipodystrophy caused by an R482W mutation in the LMNA gene.

external link
14.

Vigouroux C et al. (2001) Nuclear envelope disorganization in fibroblasts from lipodystrophic patients with heterozygous R482Q/W mutations in the lamin A/C gene.

external link
15.

Caux F et al. (2003) A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy.

external link
16.

Vigouroux C et al. (2003) LMNA mutations in atypical Werner's syndrome.

external link
17.

Lanktree M et al. (2007) Novel LMNA mutations seen in patients with familial partial lipodystrophy subtype 2 (FPLD2; MIM 151660).

external link
18.

None (2003) Drawing the line in progeria syndromes.

external link
19.

Chen L et al. (2003) LMNA mutations in atypical Werner's syndrome.

external link
20.

Nguyen D et al. (2007) Collagen expression in fibroblasts with a novel LMNA mutation.

external link
21.

McPherson E et al. (2009) Ovarian failure and dilated cardiomyopathy due to a novel lamin mutation.

external link
22.

Bonne G et al. (1999) Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy.

external link
23.

None (2000) Pushing the envelope on lipodystrophy.

external link
24.

Raffaele Di Barletta M et al. (2000) Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy.

external link
25.

Muchir A et al. (2000) Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B).

external link
26.

Hegele RA et al. (2000) LMNA R482Q mutation in partial lipodystrophy associated with reduced plasma leptin concentration.

external link
27.

Hegele RA et al. (2000) Genetic variation in LMNA modulates plasma leptin and indices of obesity in aboriginal Canadians.

external link
28.

Genschel J et al. (2000) Mutations in the LMNA gene encoding lamin A/C.

external link
29.

Hegele RA et al. (2001) Common genomic variation in LMNA modulates indexes of obesity in Inuit.

external link
30.

Brown CA et al. (2001) Novel and recurrent mutations in lamin A/C in patients with Emery-Dreifuss muscular dystrophy.

external link
31.

De Sandre-Giovannoli A et al. (2002) Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse.

external link
32.

Novelli G et al. (2002) Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C.

external link
33.

van der Kooi AJ et al. (2002) Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy.

external link
34.

De Sandre-Giovannoli A et al. (2003) Lamin a truncation in Hutchinson-Gilford progeria.

external link
35.

Eriksson M et al. (2003) Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome.

external link
36.

Mounkes LC et al. (2003) A progeroid syndrome in mice is caused by defects in A-type lamins.

external link
37.

Cao H et al. (2003) LMNA is mutated in Hutchinson-Gilford progeria (MIM 176670) but not in Wiedemann-Rautenstrauch progeroid syndrome (MIM 264090).

external link
38.

Cogulu O et al. (2003) Mandibuloacral dysplasia with absent breast development.

external link
39.

Simha V et al. (2003) Genetic and phenotypic heterogeneity in patients with mandibuloacral dysplasia-associated lipodystrophy.

external link
40.

Shen JJ et al. (2003) Mandibuloacral dysplasia caused by homozygosity for the R527H mutation in lamin A/C.

external link
41.

Favreau C et al. (2004) Expression of a mutant lamin A that causes Emery-Dreifuss muscular dystrophy inhibits in vitro differentiation of C2C12 myoblasts.

external link
42.

Lammerding J et al. (2004) Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction.

external link
43.

D'Apice MR et al. (2004) Paternal origin of LMNA mutations in Hutchinson-Gilford progeria.

external link
44.

Csoka AB et al. (2004) Novel lamin A/C gene (LMNA) mutations in atypical progeroid syndromes.

external link
45.

Mercuri E et al. (2004) Extreme variability of phenotype in patients with an identical missense mutation in the lamin A/C gene: from congenital onset with severe phenotype to milder classic Emery-Dreifuss variant.

external link
46.

Goldman RD et al. (2004) Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome.

external link
47.

Plasilova M et al. (2004) Homozygous missense mutation in the lamin A/C gene causes autosomal recessive Hutchinson-Gilford progeria syndrome.

external link
48.

Navarro CL et al. (2004) Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy.

external link
49.

Reddel CJ et al. (2004) Lamin A expression levels are unperturbed at the normal and mutant alleles but display partial splice site selection in Hutchinson-Gilford progeria syndrome.

external link
50.

Broers JL et al. (2004) Decreased mechanical stiffness in LMNA-/- cells is caused by defective nucleo-cytoskeletal integrity: implications for the development of laminopathies.

external link
51.

Vantyghem MC et al. (2004) Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities.

external link
52.

Arimura T et al. (2005) Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies.

external link
53.

Kirschner J et al. (2005) p.S143F mutation in lamin A/C: a new phenotype combining myopathy and progeria.

external link
54.

van Engelen BG et al. (2005) The lethal phenotype of a homozygous nonsense mutation in the lamin A/C gene.

external link
55.

Scaffidi P et al. (2005) Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome.

external link
56.

Mercuri E et al. (2005) Extreme variability of skeletal and cardiac muscle involvement in patients with mutations in exon 11 of the lamin A/C gene.

external link
57.

Wuyts W et al. (2005) Somatic and gonadal mosaicism in Hutchinson-Gilford progeria.

external link
58.

Navarro CL et al. (2005) Loss of ZMPSTE24 (FACE-1) causes autosomal recessive restrictive dermopathy and accumulation of Lamin A precursors.

external link
59.

Capanni C et al. (2005) Altered pre-lamin A processing is a common mechanism leading to lipodystrophy.

external link
60.

None (2005) LMNA mutation position predicts organ system involvement in laminopathies.

external link
61.

D'Amico A et al. (2005) Two patients with 'Dropped head syndrome' due to mutations in LMNA or SEPN1 genes.

external link
62.

Sinkovec M et al. (2005) Familial progressive sinoatrial and atrioventricular conduction disease of adult onset with sudden death, dilated cardiomyopathy, and brachydactyly. A new type of heart-hand syndrome?

external link
63.

Garg A et al. (2005) A novel homozygous Ala529Val LMNA mutation in Turkish patients with mandibuloacral dysplasia.

external link
64.

Yang SH et al. (2005) Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation.

external link
65.

Van Berlo JH et al. (2005) A-type lamins are essential for TGF-beta1 induced PP2A to dephosphorylate transcription factors.

external link
66.

Glynn MW et al. (2005) Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition.

external link
67.

Capell BC et al. (2005) Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome.

external link
68.

Toth JI et al. (2005) Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes.

external link
69.

Jacob KN et al. (2005) Phenotypic heterogeneity in body fat distribution in patients with atypical Werner's syndrome due to heterozygous Arg133Leu lamin A/C mutation.

external link
70.

Mallampalli MP et al. (2005) Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome.

external link
71.

Huang S et al. (2005) Correction of cellular phenotypes of Hutchinson-Gilford Progeria cells by RNA interference.

external link
72.

Van Esch H et al. (2006) A homozygous mutation in the lamin A/C gene associated with a novel syndrome of arthropathy, tendinous calcinosis, and progeroid features.

external link
73.

Boguslavsky RL et al. (2006) Nuclear lamin A inhibits adipocyte differentiation: implications for Dunnigan-type familial partial lipodystrophy.

external link
74.

Frock RL et al. (2006) Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation.

external link
75.

Varga R et al. (2006) Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome.

external link
76.

Morel CF et al. (2006) A LMNA splicing mutation in two sisters with severe Dunnigan-type familial partial lipodystrophy type 2.

external link
77.

Scaffidi P et al. (2006) Lamin A-dependent nuclear defects in human aging.

external link
78.

Shumaker DK et al. (2006) Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging.

external link
79.

Yang SH et al. (2006) A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation.

external link
80.

Rudnik-Schöneborn S et al. (2007) Mutations of the LMNA gene can mimic autosomal dominant proximal spinal muscular atrophy.

external link
81.

Capell BC et al. (2006) Human laminopathies: nuclei gone genetically awry.

external link
82.

Benedetti S et al. (2007) Phenotypic clustering of lamin A/C mutations in neuromuscular patients.

external link
83.

Muchir A et al. (2007) Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy.

external link
84.

Worman HJ et al. (2007) "Laminopathies": a wide spectrum of human diseases.

external link
85.

Moulson CL et al. (2007) Increased progerin expression associated with unusual LMNA mutations causes severe progeroid syndromes.

external link
86.

Ben Yaou R et al. (2007) Multitissular involvement in a family with LMNA and EMD mutations: Role of digenic mechanism?

external link
87.

Coffinier C et al. (2007) HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells.

external link
88.

Decaudain A et al. (2007) New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome.

external link
89.

Lombardi F et al. (2007) Compound heterozygosity for mutations in LMNA in a patient with a myopathic and lipodystrophic mandibuloacral dysplasia type A phenotype.

external link
90.

Kandert S et al. (2007) Nesprin-2 giant safeguards nuclear envelope architecture in LMNA S143F progeria cells.

external link
91.

Kosho T et al. (2007) Mandibuloacral dysplasia and a novel LMNA mutation in a woman with severe progressive skeletal changes.

external link
92.

Scaffidi P et al. (2008) Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing.

external link
93.

Zirn B et al. (2008) Association of homozygous LMNA mutation R471C with new phenotype: mandibuloacral dysplasia, progeria, and rigid spine muscular dystrophy.

external link
94.

Rankin J et al. (2008) Extreme phenotypic diversity and nonpenetrance in families with the LMNA gene mutation R644C.

external link
95.

Quijano-Roy S et al. (2008) De novo LMNA mutations cause a new form of congenital muscular dystrophy.

external link
96.

Renou L et al. (2008) Heart-hand syndrome of Slovenian type: a new kind of laminopathy.

external link
97.

Yang SH et al. (2008) Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated.

external link
98.

Muchir A et al. (2009) Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins.

external link
99.

Makri S et al. (2009) Germinal mosaicism for LMNA mimics autosomal recessive congenital muscular dystrophy.

external link
100.

Rodriguez S et al. (2009) Increased expression of the Hutchinson-Gilford progeria syndrome truncated lamin A transcript during cell aging.

external link
101.

Garavelli L et al. (2009) Mandibuloacral dysplasia type A in childhood.

external link
102.

Møller DV et al. (2009) The role of Lamin A/C mutations in Danish patients with idiopathic dilated cardiomyopathy.

external link
103.

Haque F et al. (2010) Mammalian SUN protein interaction networks at the inner nuclear membrane and their role in laminopathy disease processes.

external link
104.

Małek LA et al. (2011) A new c.1621 C > G, p.R541G lamin A/C mutation in a family with DCM and regional wall motion abnormalities (akinesis/dyskinesis): genotype-phenotype correlation.

external link
105.

Liu GH et al. (2011) Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome.

external link
106.

Chen CY et al. (2012) Accumulation of the inner nuclear envelope protein Sun1 is pathogenic in progeric and dystrophic laminopathies.

external link
107.

Krohne G et al. (1986) The nuclear lamins. A multigene family of proteins in evolution and differentiation.

external link
108.

Weber K et al. (1989) Maturation of nuclear lamin A involves a specific carboxy-terminal trimming, which removes the polyisoprenylation site from the precursor; implications for the structure of the nuclear lamina.

external link
109.

Lebel S et al. (1987) Lamin A is not synthesized as a larger precursor polypeptide.

external link
110.

McKeon FD et al. () Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins.

external link
111.

Fisher DZ et al. (1986) cDNA sequencing of nuclear lamins A and C reveals primary and secondary structural homology to intermediate filament proteins.

external link
112.

Guilly MN et al. (1987) A human T lymphoblastic cell line lacks lamins A and C.

external link
113.

Sinensky M et al. (1994) The processing pathway of prelamin A.

external link
114.

Lin F et al. (1993) Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C.

external link
115.

Wydner KL et al. (1996) Chromosomal assignment of human nuclear envelope protein genes LMNA, LMNB1, and LBR by fluorescence in situ hybridization.

external link
116.

NCBI article

NCBI 4000 external link
117.

OMIM.ORG article

Omim 150330 external link
118.

Orphanet article

Orphanet ID 123090 external link
119.

Wikipedia article

Wikipedia EN (LMNA) external link
Update: Aug. 14, 2020
Copyright © 2005-2020 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944
Sitemap | Webmail | Disclaimer | Privacy Issues